Effects of Nefopam on Streptozotocin-Induced Diabetic Neuropathic Pain in Rats

BACKGROUND: Nefopam is a centrally acting non-opioid analgesic agent. Its analgesic properties may be related to the inhibitions of monoamine reuptake and the N-methyl-D-aspartate (NMDA) receptor. The antinociceptive effect of nefopam has been shown in animal models of acute and chronic pain and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Jae Sik, Cheong, Yu Seon, Karm, Myong Hwan, Ahn, Ho Soo, Sim, Ji Hoon, Kim, Jin Sun, Choi, Seong Soo, Leem, Jeong Gil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Pain Society 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196497/
https://www.ncbi.nlm.nih.gov/pubmed/25317281
http://dx.doi.org/10.3344/kjp.2014.27.4.326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196497/
https://www.ncbi.nlm.nih.gov/pubmed/25317281
http://dx.doi.org/10.3344/kjp.2014.27.4.326

Ejemplares similares